Recent biomarkers for the identification of patients at risk for preeclampsia: the role of uteroplacental ischemia

Bibliography

• Ilekis JV, Reddy UM, Roberts JM. Preeclampsia–a pressing problem: an executive summary of a National Institute of Child Health and Human Development workshop. Reprod Sci 2007;14:508-23
   PubMed Web of Science ®Google Scholar
• Bujold E, Morency AM, Roberge S, Acetylsalicylic acid for the prevention of preeclampsia and intra-uterine growth restriction in women with abnormal uterine artery Doppler: a systematic review and meta-analysis. J Obstet Gynaecol Can 2009;31:818-26
   PubMedGoogle Scholar
• Dekker GA, Sibai BM. Etiology and pathogenesis of preeclampsia: current concepts. Am J Obstet Gynecol 1998;179:1359-75
   PubMed Web of Science ®Google Scholar
• Austgulen R, Isaksen CV, Chedwick L, Pre-eclampsia: associated with increased syncytial apoptosis when the infant is small-for-gestational-age. J Reprod Immunol 2004;61:39-50
   PubMed Web of Science ®Google Scholar
• Crocker IP, Cooper S, Ong SC, Baker PN. Differences in apoptotic susceptibility of cytotrophoblasts and syncytiotrophoblasts in normal pregnancy to those complicated with preeclampsia and intrauterine growth restriction. Am J Pathol 2003;162:637-43
   PubMed Web of Science ®Google Scholar
• Leung DN, Smith SC, To KF, Increased placental apoptosis in pregnancies complicated by preeclampsia. Am J Obstet Gynecol 2001;184:1249-50
   PubMed Web of Science ®Google Scholar
• Sargent IL, Germain SJ, Sacks GP, Trophoblast deportation and the maternal inflammatory response in pre-eclampsia. J Reprod Immunol 2003;59:153-60
   PubMed Web of Science ®Google Scholar
• Johansen M, Redman CW, Wilkins T, Sargent IL. Trophoblast deportation in human pregnancy: its relevance for pre-eclampsia. Placenta 1999;20:531-9
   PubMed Web of Science ®Google Scholar
• Knight M, Redman CW, Linton EA, Sargent IL. Shedding of syncytiotrophoblast microvilli into the maternal circulation in pre-eclamptic pregnancies. Br J Obstet Gynaecol 1998;105:632-40
   PubMedGoogle Scholar
• Chua S, Wilkins T, Sargent I, Redman C. Trophoblast deportation in pre-eclamptic pregnancy. Br J Obstet Gynaecol 1991;98:973-9
   PubMedGoogle Scholar
• Levine RJ, Lam C, Qian C, Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006;355:992-1005
   PubMed Web of Science ®Google Scholar
• Maynard SE, Min JY, Merchan J, Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003;111:649-58
   PubMed Web of Science ®Google Scholar
• Espinoza J, Uckele JE, Starr RA, Angiogenic imbalances: the obstetric perspective. Am J Obstet Gynecol 2010;203:17-18
   PubMed Web of Science ®Google Scholar
• Makris A, Thornton C, Thompson J, Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1. Kidney Int 2007;71:977-84
   PubMed Web of Science ®Google Scholar
• Gilbert JS, Babcock SA, Granger JP. Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression. Hypertension 2007;50:1142-7
   PubMed Web of Science ®Google Scholar
• Nagamatsu T, Fujii T, Kusumi M, Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia. Endocrinology 2004;145:4838-45
   PubMed Web of Science ®Google Scholar
• Nevo O, Soleymanlou N, Wu Y, Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1. Am J Physiol Regul Integr Comp Physiol 2006;291:R1085-93
   PubMed Web of Science ®Google Scholar
• Chaiworapongsa T, Espinoza J, Gotsch F, The maternal plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated in SGA and the magnitude of the increase relates to Doppler abnormalities in the maternal and fetal circulation. J Matern Fetal Neonatal Med 2008;21:25-40
   PubMed Web of Science ®Google Scholar
• Page EW. The relation between hydatid moles, relative ischemia of the gravid uterus, and the placental origin of eclampsia. Am J Obstet Gynecol 1939;37:291-3
   Google Scholar
• Bolin M, Wiberg-Itzel E, Wikstrom AK, Angiopoietin-1/angiopoietin-2 ratio for prediction of preeclampsia. Am J Hypertens 2009;22:891-5
   PubMed Web of Science ®Google Scholar
• Kusanovic JP, Romero R, Chaiworapongsa T, A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia. J Matern Fetal Neonatal Med 2009;22:1021-38
   PubMed Web of Science ®Google Scholar
• Poon LC, Maiz N, Valencia C, First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia. Ultrasound Obstet Gynecol 2009;33:23-33
   PubMed Web of Science ®Google Scholar
• Espinoza J, Romero R, Nien JK, Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor. Am J Obstet Gynecol 2007;196:326-13
   PubMedGoogle Scholar
• Harrington K, Cooper D, Lees C, Doppler ultrasound of the uterine arteries: the importance of bilateral notching in the prediction of pre-eclampsia, placental abruption or delivery of a small-for-gestational-age baby. Ultrasound Obstet Gynecol 1996;7:182-8
   PubMed Web of Science ®Google Scholar
• Albaiges G, Missfelder-Lobos H, Lees C, One-stage screening for pregnancy complications by color Doppler assessment of the uterine arteries at 23 weeks' gestation. Obstet Gynecol 2000;96:559-64
   PubMed Web of Science ®Google Scholar
• Papageorghiou AT, Yu CK, Cicero S, Second-trimester uterine artery Doppler screening in unselected populations: a review. J Matern Fetal Neonatal Med 2002;12:78-88
   PubMedGoogle Scholar
• Papageorghiou AT, Yu CK, Bindra R, Multicenter screening for pre-eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation. Ultrasound Obstet Gynecol 2001;18:441-9
   PubMed Web of Science ®Google Scholar
• Tjoa ML, van Vugt JM, Mulders MA, Plasma placenta growth factor levels in midtrimester pregnancies. Obstet Gynecol 2001;98:600-7
   PubMed Web of Science ®Google Scholar
• Tidwell SC, Ho HN, Chiu WH, Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia. Am J Obstet Gynecol 2001;184:1267-72
   PubMed Web of Science ®Google Scholar
• Chappell LC, Seed PT, Briley A, A longitudinal study of biochemical variables in women at risk of preeclampsia. Am J Obstet Gynecol 2002;187:127-36
   PubMed Web of Science ®Google Scholar
• Taylor RN, Grimwood J, Taylor RS, Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies. Am J Obstet Gynecol 2003;188:177-82
   PubMed Web of Science ®Google Scholar
• Polliotti BM, Fry AG, Saller DN, Second-trimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe, early-onset preeclampsia. Obstet Gynecol 2003;101:1266-74
   PubMed Web of Science ®Google Scholar
• Krauss T, Pauer HU, Augustin HG. Prospective analysis of placenta growth factor (PlGF) concentrations in the plasma of women with normal pregnancy and pregnancies complicated by preeclampsia. Hypertens Pregnancy 2004;23:101-11
   PubMed Web of Science ®Google Scholar
• Levine RJ, Maynard SE, Qian C, Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004;350:672-83
   PubMed Web of Science ®Google Scholar
• Parra M, Rodrigo R, Barja P, Screening test for preeclampsia through assessment of uteroplacental blood flow and biochemical markers of oxidative stress and endothelial dysfunction. Am J Obstet Gynecol 2005;193:1486-91
   PubMed Web of Science ®Google Scholar
• Chaiworapongsa T, Romero R, Kim YM, Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia. J Matern Fetal Neonatal Med 2005;17:3-18
   PubMed Web of Science ®Google Scholar
• Moore Simas TA, Crawford SL, Solitro MJ, Angiogenic factors for the prediction of preeclampsia in high-risk women. Am J Obstet Gynecol 2007;197:244-8
   PubMed Web of Science ®Google Scholar
• Ohkuchi A, Hirashima C, Matsubara S, Alterations in placental growth factor levels before and after the onset of preeclampsia are more pronounced in women with early onset severe preeclampsia. Hypertens Res 2007;30:151-9
   PubMed Web of Science ®Google Scholar
• Poon LC, Zaragoza E, Akolekar R, Maternal serum placental growth factor (PlGF) in small for gestational age pregnancy at 11(+0) to 13(+6) weeks of gestation. Prenat Diagn 2008;28:1110-15
   PubMed Web of Science ®Google Scholar
• Erez O, Romero R, Espinoza J, The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age. J Matern Fetal Neonatal Med 2008;21:279-87
   PubMed Web of Science ®Google Scholar
• Poon LC, Kametas NA, Maiz N, First-trimester prediction of hypertensive disorders in pregnancy. Hypertension 2009;53:812-18
   PubMed Web of Science ®Google Scholar
• Thadhani R, Mutter WP, Wolf M, First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. J Clin Endocrinol Metab 2004;89:770-5
   PubMed Web of Science ®Google Scholar
• Rana S, Karumanchi SA, Levine RJ, Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia. Hypertension 2007;50:137-42
   PubMed Web of Science ®Google Scholar
• Baumann MU, Bersinger NA, Mohaupt MG, First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia. Am J Obstet Gynecol 2008;199:266
   PubMed Web of Science ®Google Scholar
• Romero R, Nien JK, Espinoza J, A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med 2008;21:9-23
   PubMed Web of Science ®Google Scholar
• Schmidt M, Dogan C, Birdir C, Placental growth factor: a predictive marker for preeclampsia? Gynakol Geburtshilfliche Rundsch 2009;49:94-9
   PubMedGoogle Scholar
• Stepan H, Geipel A, Schwarz F, Circulatory soluble endoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion. Am J Obstet Gynecol 2008;198:175-6
   PubMed Web of Science ®Google Scholar
• Burger O, Pick E, Zwickel J, Placental protein 13 (PP-13): effects on cultured trophoblasts, and its detection in human body fluids in normal and pathological pregnancies. Placenta 2004;25:608-22
   PubMed Web of Science ®Google Scholar
• Romero R, Kusanovic JP, Than NG, First-trimester maternal serum PP13 in the risk assessment for preeclampsia. Am J Obstet Gynecol 2008;199:122
   PubMed Web of Science ®Google Scholar
• Nicolaides KH, Bindra R, Turan OM, A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound. Ultrasound Obstet Gynecol 2006;27:13-17
   PubMed Web of Science ®Google Scholar
• Spencer K, Cowans NJ, Chefetz I, First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia. Ultrasound Obstet Gynecol 2007;29:128-34
   PubMed Web of Science ®Google Scholar
• Espinoza J, Kusanovic JP, Bahado-Singh R, Should bilateral uterine artery notching be used in the risk assessment for preeclampsia, small-for-gestational-age, and gestational hypertension? J Ultrasound Med 2010;29:1103-15
   PubMed Web of Science ®Google Scholar
• ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists. Int J Gynaecol.Obstet 2002;77:67-75
   PubMed Web of Science ®Google Scholar
• Chaiworapongsa T, Romero R, Savasan ZA, Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia. J Matern Fetal Neonatal Med 2011;24:1187-207
   PubMed Web of Science ®Google Scholar
• Stepan H, Schaarschmidt W, Jank A, Use of angiogenic factors (sFlt-1/PlGF ratio) to confirm the diagnosis of preeclampsia in clinical routine: first experience. Z Geburtshilfe Neonatol 2010;214(6):234-8
   PubMedGoogle Scholar
• Thadhani R, Kisner T, Hagmann H, Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia. Circulation 2011;124:940-50
   PubMed Web of Science ®Google Scholar
• Espinoza J, Romero R, Mee KY, Normal and abnormal transformation of the spiral arteries during pregnancy. J Perinat Med 2006;34:447-58
   PubMed Web of Science ®Google Scholar
• Pijnenborg R, Vercruysse L, Hanssens M. The uterine spiral arteries in human pregnancy: facts and controversies. Placenta 2006;27:939-58
   PubMed Web of Science ®Google Scholar
• Olofsson P, Laurini RN, Marsal K. A high uterine artery pulsatility index reflects a defective development of placental bed spiral arteries in pregnancies complicated by hypertension and fetal growth retardation. Eur J Obstet Gynecol Reprod Biol 1993;49:161-8
   PubMed Web of Science ®Google Scholar
• Voigt HJ, Becker V. Doppler flow measurements and histomorphology of the placental bed in uteroplacental insufficiency. J Perinat Med 1992;20:139-47
   PubMed Web of Science ®Google Scholar
• Lin S, Shimizu I, Suehara N, Uterine artery Doppler velocimetry in relation to trophoblast migration into the myometrium of the placental bed. Obstet Gynecol 1995;85:760-5
   PubMed Web of Science ®Google Scholar
• Aardema MW, Oosterhof H, Timmer A, Uterine artery Doppler flow and uteroplacental vascular pathology in normal pregnancies and pregnancies complicated by pre-eclampsia and small for gestational age fetuses. Placenta 2001;22:405-11
   PubMed Web of Science ®Google Scholar
• Sagol S, Ozkinay E, Oztekin K, Ozdemir N. The comparison of uterine artery Doppler velocimetry with the histopathology of the placental bed. Aust N Z J Obstet Gynaecol 1999;39:324-9
   PubMed Web of Science ®Google Scholar
• Madazli R, Somunkiran A, Calay Z, Histomorphology of the placenta and the placental bed of growth restricted foetuses and correlation with the Doppler velocimetries of the uterine and umbilical arteries. Placenta 2003;24:510-16
   PubMed Web of Science ®Google Scholar
• Kim YM, Chaiworapongsa T, Gomez R, Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes. Am J Obstet Gynecol 2002;187:1137-42
   PubMed Web of Science ®Google Scholar
• Kim YM, Bujold E, Chaiworapongsa T, Failure of physiologic transformation of the spiral arteries in patients with preterm labor and intact membranes. Am J Obstet Gynecol 2003;189:1063-9
   PubMed Web of Science ®Google Scholar
• Ogge G, Chaiworapongsa T, Romero R, Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia. J Perinat Med 2011;39:641-52
   PubMed Web of Science ®Google Scholar
• Soto E, Romero R, Kusanovic JP, Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion. J Matern Fetal Neonatal Med 2011 [Epub ahead of print]
   Web of Science ®Google Scholar
• Benirschke K, Kaufmann P, Baergen R. In: Benirschke K, Kaufmann P, Baergen R. editor. Pathology of the Human Placenta. Springer; New York: 2006
   Google Scholar
• Sandrim VC, Palei AC, Cavalli RC, Vascular endothelial growth factor genotypes and haplotypes are associated with pre-eclampsia but not with gestational hypertension. Mol Hum Reprod 2009;15:115-20
   PubMed Web of Science ®Google Scholar
• Espinoza J, Espinoza AF. Pre-eclampsia: a maternal manifestation of a fetal adaptive response? Ultrasound Obstet Gynecol 2011;38:367-70
   PubMed Web of Science ®Google Scholar
• Espinoza J, Espinoza AF, Power GG. High fetal plasma adenosine concentration: a role for the fetus in preeclampsia? Am J Obstet Gynecol 2011;205:485.e24-7
   PubMedGoogle Scholar
• Rasmussen S, Irgens LM. Fetal growth and body proportion in preeclampsia. Obstet Gynecol 2003;101:575-83
   PubMed Web of Science ®Google Scholar
• Aardema MW, Saro MC, Lander M, Second trimester Doppler ultrasound screening of the uterine arteries differentiates between subsequent normal and poor outcomes of hypertensive pregnancy: two different pathophysiological entities? Clin Sci (Lond) 2004;106:377-82
   PubMed Web of Science ®Google Scholar
• Odegard RA, Vatten LJ, Nilsen ST, Preeclampsia and fetal growth. Obstet Gynecol 2000;96:950-5
   PubMed Web of Science ®Google Scholar
• Xiong X, Demianczuk NN, Buekens P, Saunders LD. Association of preeclampsia with high birth weight for age. Am J Obstet Gynecol 2000;183:148-55
   PubMed Web of Science ®Google Scholar
• Xiong X, Fraser WD. Impact of pregnancy-induced hypertension on birthweight by gestational age. Paediatr Perinat Epidemiol 2004;18:186-91
   PubMed Web of Science ®Google Scholar
• Benton SJ, Hu Y, Xie F, Angiogenic factors as diagnostic tests for preeclampsia: a performance comparison between two commercial immunoassays. Am J Obstet Gynecol 2011;205:469-8
   PubMed Web of Science ®Google Scholar
• Sunderji S, Gaziano E, Wothe D, Automated assays for sVEGF R1 and PlGF as an aid in the diagnosis of preterm preeclampsia: a prospective clinical study. Am J Obstet Gynecol 2010;202:40-7
   PubMed Web of Science ®Google Scholar
• Verlohren S, Galindo A, Schlembach D, An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia. Am J Obstet Gynecol 2010;202:161
   PubMed Web of Science ®Google Scholar
• Knudsen UB, Kronborg CS, von Dadelszen P, A single rapid point-of-care placental growth factor determination as an aid in the diagnosis of preeclampsia. Pregnancy Hypertension: an International Journal of Women's Cardiovascular Health 2012;2:8-15
   Web of Science ®Google Scholar
• Levine RJ, Lindheimer MD. First-trimester prediction of early preeclampsia: a possibility at last!. Hypertension 2009;53:747-8
   PubMed Web of Science ®Google Scholar
• Khalil A, Cowans NJ, Spencer K, First trimester maternal serum placental protein 13 for the prediction of pre-eclampsia in women with a priori high risk. Prenat Diagn 2009;29:781-9
   PubMed Web of Science ®Google Scholar
• Wortelboer EJ, Koster MP, Cuckle HS, First-trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early-onset pre-eclampsia. BJOG 2010;117:1384-9
   PubMed Web of Science ®Google Scholar
• Odibo AO, Zhong Y, Goetzinger KR, First-trimester placental protein 13, PAPP-A, uterine artery Doppler and maternal characteristics in the prediction of pre-eclampsia. Placenta 2011;32:598-602
   PubMed Web of Science ®Google Scholar
• Thilaganathan B, Wormald B, Zanardini C, Early-pregnancy multiple serum markers and second-trimester uterine artery Doppler in predicting preeclampsia. Obstet Gynecol 2010;115:1233-8
   PubMed Web of Science ®Google Scholar
• Yu J, Shixia CZ, Wu Y, Duan T. Inhibin A, activin A, placental growth factor and uterine artery Doppler pulsatility index in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol 2011;37:528-33
   PubMed Web of Science ®Google Scholar
• Youssef A, Righetti F, Morano D, Uterine artery Doppler and biochemical markers (PAPP-A, PlGF, sFlt-1, P-selectin, NGAL) at 11 + 0 to 13 + 6 weeks in the prediction of late (> 34 weeks) pre-eclampsia. Prenat Diagn 2011;31:1141-6
   PubMed Web of Science ®Google Scholar
• Stepan H, Unversucht A, Wessel N, Faber R. Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion. Hypertension 2007;49:818-24
   PubMed Web of Science ®Google Scholar
• Espinoza J, Romero R, Kusanovic JP, Maternal plasma concentrations of placental growth factor (PlGF) and soluble endoglin (s-Eng) in the second trimester identify patients destined to develop early-onset preeclampsia. Am J Obstet Gynecol 2007;197:S136
   Web of Science ®Google Scholar
• Crispi F, Llurba E, Dominguez C, Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction. Ultrasound Obstet Gynecol 2008;31:303-9
   PubMed Web of Science ®Google Scholar
• Diab AE, El Behery MM, Ebrahiem MA, Shehata AE. Angiogenic factors for the prediction of pre-eclampsia in women with abnormal midtrimester uterine artery Doppler velocimetry. Int J Gynaecol Obstet 2008;102:146-51
   PubMed Web of Science ®Google Scholar
• Sibai BM, Koch MA, Freire S, Serum inhibin A and angiogenic factor levels in pregnancies with previous preeclampsia and/or chronic hypertension: are they useful markers for prediction of subsequent preeclampsia? Am J Obstet Gynecol 2008;199:268-9
   PubMed Web of Science ®Google Scholar
• Hertig A, Berkane N, Lefevre G, Maternal serum sFlt1 concentration is an early and reliable predictive marker of preeclampsia. Clin Chem 2004;50:1702-3
   PubMed Web of Science ®Google Scholar
• Lim JH, Kim SY, Park SY, Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors. Obstet Gynecol 2008;111(6):1403-9
   PubMed Web of Science ®Google Scholar
• Verlohren S, Herraiz I, Lapaire O, The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. Am J Obstet Gynecol 2012;206:58
   PubMedGoogle Scholar